CureVac NV Stock Options
| CVAC Stock | USD 3.79 0.03 0.79% |
CureVac NV's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.54 with a put-to-call open interest ratio of 0.37 over 18 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows CureVac NV's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. CureVac NV's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for CureVac NV's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on CureVac NV
Analyzing CureVac NV's in-the-money options over time can help investors to take a profitable long position in CureVac NV regardless of its overall volatility. This is especially true when CureVac NV's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money CureVac NV's options could be used as guardians of the underlying stock as they move almost dollar for dollar with CureVac NV's stock while costing only a fraction of its price.
CureVac NV's stock options are financial instruments that give investors the right to buy or sell shares of CureVac NV common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CureVac stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If CureVac NV's stock price goes up or down, the stock options follow.
At present, CureVac NV's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 11.3 M, whereas Total Stockholder Equity is forecasted to decline to about 447.2 M. CureVac NV In The Money Call Balance
When CureVac NV's strike price is surpassing the current stock price, the option contract against CureVac NV stock is said to be in the money. When it comes to buying CureVac NV's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on CureVac NV are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
CureVac Current Options Market Mood
CureVac NV's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CureVac Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of CureVac NV's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. CureVac NV's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current CureVac contract
Base on the Rule 16, the options market is currently suggesting that CureVac NV will have an average daily up or down price movement of about 0.0963% per day over the life of the 2025-04-17 option contract. With CureVac NV trading at USD 3.79, that is roughly USD 0.003648. If you think that the market is fully incorporating CureVac NV's daily price movement you should consider buying CureVac NV options at the current volatility level of 1.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
CureVac |
Purchasing CureVac NV options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CureVac calls. Remember, the seller must deliver CureVac NV stock to the call owner when a call is exercised.
CureVac NV Option Chain
When CureVac NV's strike price is surpassing the current stock price, the option contract against CureVac NV stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
CureVac NV's option chain is a display of a range of information that helps investors for ways to trade options on CureVac. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CureVac. It also shows strike prices and maturity days for a CureVac NV against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CVAC250417C00001000 | 2 | 1.0 | 0.5 - 5.3 | 3.34 | In |
Call | CVAC250417C00002000 | 115 | 2.0 | 0.1 - 4.9 | 2.26 | In |
Call | CVAC250417C00003000 | 155 | 3.0 | 1.0 - 1.4 | 1.25 | In |
Call | CVAC250417C00004000 | 282 | 4.0 | 0.45 - 0.85 | 0.7 | Out |
Call | CVAC250417C00005000 | 295 | 5.0 | 0.2 - 0.6 | 0.38 | Out |
Call | CVAC250417C00006000 | 132 | 6.0 | 0.0 - 0.45 | 0.2 | Out |
Call | CVAC250417C00007000 | 14 | 7.0 | 0.0 - 0.4 | 0.24 | Out |
Call | CVAC250417C00008000 | 0 | 8.0 | 0.0 - 0.4 | 0.4 | |
Call | CVAC250417C00009000 | 1 | 9.0 | 0.0 - 0.35 | 0.25 | Out |
Put | CVAC250417P00001000 | 0 | 1.0 | 0.0 - 0.15 | 0.15 | |
Put | CVAC250417P00002000 | 11 | 2.0 | 0.0 - 0.2 | 0.25 | Out |
Put | CVAC250417P00003000 | 8 | 3.0 | 0.2 - 0.5 | 0.34 | Out |
Put | CVAC250417P00004000 | 12 | 4.0 | 0.0 - 1.85 | 0.3 | In |
Put | CVAC250417P00005000 | 286 | 5.0 | 0.0 - 1.7 | 1.2 | In |
Put | CVAC250417P00006000 | 33 | 6.0 | 0.0 - 2.9 | 2.2 | In |
Put | CVAC250417P00007000 | 15 | 7.0 | 3.0 - 3.5 | 3.1 | In |
Put | CVAC250417P00008000 | 0 | 8.0 | 3.8 - 5.6 | 3.8 | In |
Put | CVAC250417P00009000 | 0 | 9.0 | 4.8 - 6.9 | 4.8 | In |
CureVac NV Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
CureVac NV Market Cap Over Time
Market Cap |
| Timeline |
CureVac Total Stockholder Equity
Total Stockholder Equity |
|
CureVac NV Corporate Management
| Pierre BSc | CFO MD | Profile | |
| Patrick Baumhof | Senior Technology | Profile | |
| AxelSven Malkomes | Chief Officer | Profile | |
| Ronald Plasterk | Senior Innovation | Profile | |
| Igor MSc | Chief Board | Profile | |
| Antony Blanc | Chief MD | Profile | |
| Sarah Fakih | Vice Relations | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.49 | Revenue Per Share | Quarterly Revenue Growth 0.905 | Return On Assets | Return On Equity |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.